These effects mediated by OR2T6 are associated with MAPK/ERK signaling pathway and epithelial-mesenchymal transition, as confirmed by the specific OR2T6 overexpression or knock-down in breast cancer cell lines as well as microarray and Western blot analysis [123]. This evidence concerns the gene OR2T6 and breast cancer.